{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:18:46Z","timestamp":1790867926756,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1996,5,1]],"date-time":"1996-05-01T00:00:00Z","timestamp":830908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1996,5]]},"DOI":"10.1007\/s002770050179","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T04:03:26Z","timestamp":1030248206000},"page":"321-326","source":"Crossref","is-referenced-by-count":32,"title":["Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects"],"prefix":"10.1007","volume":"72","author":[{"given":"J.","family":"Batlle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"G\u00f6mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rendal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Torea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lour\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Couselo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sedano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Tusell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Magall\u00f6n\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gonz\u00e1lez-Boullosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"L\u00f6pez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"60720321277_CR1","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1073\/pnas.89.9.3795","volume":"89","author":"M Algiman","year":"1992","unstructured":"Algiman M, Dietrich G, Nydegger UE, Boieldieu D, Sultan Y, Kazatchkine (1992) Natural antibodies to factor VIII (antihemophilic factor) in healthy individuals. Proc Natl Acad Sci USA 89: 3795\u20133799","journal-title":"Proc Natl Acad Sci USA"},{"key":"60720321277_CR2","first-page":"557","volume":"69","author":"J Batlle","year":"1993","unstructured":"Batlle J, G\u00f3mez E, Lour\u00e9s E, Sedano C, Tussell X, Magall\u00f6n M. Gonz\u00e1lez R, L\u00f3pez Fern\u00e1ndez MF (1993) Non-inhibitory antibodies to factor VIII in hemophilia A patients and normal subjects. Thromb Haemost 69: 557 (abstract)","journal-title":"Thromb Haemost"},{"key":"60720321277_CR3","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1055\/s-0038-1642504","volume":"71","author":"E Berntorp","year":"1994","unstructured":"Berntorp E (1994) Impact of replacement therapy on the evolution of HIV infection in hemophiliacs. Thromb Haemost 71: 678\u2013683","journal-title":"Thromb Haemost"},{"key":"60720321277_CR4","first-page":"181","volume":"150","author":"HH Brackmann","year":"1986","unstructured":"Brackmann HH (1986) Induced immunotolerance in factor VIII inhibitor patients. Prog Clin Biol Res 150: 181\u2013195","journal-title":"Prog Clin Biol Res"},{"key":"60720321277_CR5","first-page":"677a","volume":"65","author":"GL Bray","year":"1992","unstructured":"Bray GL, Kroner BS, Arkin S, Aledort L, Hilgartner MW, Eyster ME, Ragni M, Goedert and the Multi-Center Study of AIDS in hemophilia (1992) Natural history of inhibitory loss in human immunodeficiency virus (HIV) infected patients with hemophilia A. Thromb Haemostas 65: 677a (abstract)","journal-title":"Thromb Haemostas"},{"key":"60720321277_CR6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-0038-1647059","volume":"60","author":"LO Carreras","year":"1988","unstructured":"Carreras LO, P\u00e9rez GN, Xavier DL, Blanco AN, Penalva LB (1988) Autoimmune factor VIII inhibitor responsive to gammaglobulin without in vitro neutralization. Thromb Haemostas 60: 343","journal-title":"Thromb Haemostas"},{"key":"60720321277_CR7","first-page":"1215","volume":"73","author":"PP Chaudhary","year":"1995","unstructured":"Chaudhary PP, Scandella D, Hoyer L (1995) Antibodies to factor VIII in healthy individuals bind to the A2 domain. Thromb Haemostas 73: 1215 (abstract)","journal-title":"Thromb Haemostas"},{"key":"60720321277_CR8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1182\/blood.V64.3.672.672","volume":"64","author":"B Fuente De la","year":"1984","unstructured":"De la Fuente B, Hoyer LW (1984) The idiotypic characteristics of human antibodies to factor VIII. Blood 64: 672\u2013678","journal-title":"Blood"},{"key":"60720321277_CR9","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1182\/blood.V79.11.2946.2946","volume":"79","author":"G Dietrich","year":"1992","unstructured":"Dietrich G, Algiman M, Sultan Y, Nydegger UE, Kazatchkine M (1992) Origin of anti-idiotypic activity anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg). Blood 79: 2946\u20132951","journal-title":"Blood"},{"key":"60720321277_CR10","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0140-6736(92)90874-3","volume":"339","author":"S Ehrenforth","year":"1992","unstructured":"Ehrenforth S, Kreuz W, Scharrer I, Linde R, Funk M, G\u00fcng\u00f6r T, Krackhardt B, Kornhuber B (1992) Incidence of development of factor VIII and factor IX inhibitors in hemophiliacs. Lancet 339: 594\u2013598","journal-title":"Lancet"},{"key":"60720321277_CR11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0268-960X(89)90015-5","volume":"3","author":"PA Foster","year":"1989","unstructured":"Foster PA, Zimmerman TS (1989) Factor VIII structure and function. Blood Rev 3: 180\u2013191","journal-title":"Blood Rev"},{"key":"60720321277_CR12","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0140-6736(84)92764-8","volume":"2","author":"D Frommel","year":"1984","unstructured":"Frommel D (1984) Anti-idiotypic suppression of antibodies to factor VIIIc. Lancet 2: 1210","journal-title":"Lancet"},{"key":"60720321277_CR13","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1073\/pnas.82.22.7728","volume":"82","author":"CA Fulcher","year":"1985","unstructured":"Fulcher CA, de Graaf Mahoney S, Roberts JR, Kasper CK, Zimmerman TS (1985) Localization of human factor VIII inhibitor epitopes to two polypeptide fragments. Proc Natl Acad Sci USA 82: 7728\u20137732","journal-title":"Proc Natl Acad Sci USA"},{"key":"60720321277_CR14","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1182\/blood.V69.5.1475.1475","volume":"69","author":"CA Fulcher","year":"1987","unstructured":"Fulcher CA, de Graaf Mahoney S, Zimmerman TS (1987) FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting. Blood 69: 1475\u20131480","journal-title":"Blood"},{"key":"60720321277_CR15","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1182\/blood.V72.4.1348.1348","volume":"72","author":"CA Fulcher","year":"1988","unstructured":"Fulcher CA, Lechner K, de Graaf Mahoney S (1988) Immunoblot analysis shows changes in factor VIII inhibitor chain specificity in factor VIII inhibitor patients over time. Blood 72: 1348\u20131356","journal-title":"Blood"},{"key":"60720321277_CR16","first-page":"303","volume":"48","author":"A Gianelli-Borradori","year":"1984","unstructured":"Gianelli-Borradori A, Hirt A, Luthy A, Wagner HP, Imbach P (1984) Hemophilia due to factor VIII inhibitors in a patient suffering from an autoimmune disease: treatment with intravenous immunoglobulin. Blut 48: 303\u2013307","journal-title":"Blut"},{"key":"60720321277_CR17","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1172\/JCI117489","volume":"94","author":"J Giles","year":"1994","unstructured":"Giles J, Saint-Remy J (1994) Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies. J Clin Invest 94: 1496\u20131505","journal-title":"J Clin Invest"},{"key":"60720321277_CR18","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood.V82.8.2452.2452","volume":"82","author":"J Giles","year":"1993","unstructured":"Giles J, Arnout J, Vermylen J, Saint-Remy J (1993) Anti-factor VIII antibodies of hemophiliac patients are frequently directed towards nonfunctional determinants and do not exhibit isotypic restriction. Blood 82: 2452\u20132461","journal-title":"Blood"},{"key":"60720321277_CR19","first-page":"1011","volume":"73","author":"J Giles","year":"1995","unstructured":"Giles J, Lenk H, Saint-Remy J(1995) Successful factor VIII desensitisation is accompanied by an increase in anti-FVIII anti-idiotypic antibodies without reduction of anti-FVIII antibody titers. Thromb Haemost 73: 1011 (abstract)","journal-title":"Thromb Haemost"},{"key":"60720321277_CR20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2141.1995.tb05575.x","volume":"90","author":"LW Hoyer","year":"1995","unstructured":"Hoyer LW (1995) Why do so many hemophilia A patients develop an inhibitor?. Br J Haematol 90: 498\u2013501","journal-title":"Br J Haematol"},{"key":"60720321277_CR21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1749-6632.1991.tb43695.x","volume":"614","author":"CK Kasper","year":"1991","unstructured":"Kasper CK (1991) Complications of hemophilia A treatment: factor VIII inhibitors. Ann N Y Acad Sci 614: 97\u2013105","journal-title":"Ann N Y Acad Sci"},{"key":"60720321277_CR22","first-page":"869","volume":"34","author":"CK Kasper","year":"1975","unstructured":"Kasper CK, Aledort LM, Counts RB, Edson JR, Fratantoni J, Green D, Hampton JW, Hilgartner M, Lazerson J, Levine PH, McMillan CW, Pool JG, Shapiro SS, Shulman NR, van Eys J (1975) A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 34: 869\u2013872","journal-title":"Thromb Diath Haemorrh"},{"key":"60720321277_CR23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199302183280701","volume":"328","author":"JM Lusher","year":"1993","unstructured":"Lusher JM, Arkin S, Abilgaard CF, Shwartz RS, and the Kogenate Previously Untreated Patient Study Group (1993) Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A N Engl J Med 328: 453\u2013459","journal-title":"A N Engl J Med"},{"key":"60720321277_CR24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood.V71.2.344.344","volume":"71","author":"CW McMillan","year":"1988","unstructured":"McMillan CW, Shapiro SS, Whitehurst D, Hoyer LW, Rao AV, Lazerson J and the Hemophilia Study Group (1988) The natural history of factor VIII inhibitors in patients with hemophilia A: a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitors. Blood 71: 344\u2013348","journal-title":"Blood"},{"key":"60720321277_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2141.1989.tb06279.x","volume":"71","author":"EH Moffat","year":"1989","unstructured":"Moffat EH, Furlong RA, Dannatt AH, Bloom AL, Peake IR (1989) Anti-idiotypes to factor VIII antibodies and their possible role in the pathogenesis and treatment of factor VIII inhibitors. Br J Haematol 71: 85\u201390","journal-title":"Br J Haematol"},{"key":"60720321277_CR26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM198804143181503","volume":"328","author":"IM Nilsson","year":"1988","unstructured":"Nilsson IM, Berntorp E, Zettervall O (1988) Induction of immunotolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide anf factor VIII. N Engl J Med 328: 947\u2013950","journal-title":"N Engl J Med"},{"key":"60720321277_CR27","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1182\/blood.V75.2.378.378","volume":"75","author":"IM Nilsson","year":"1990","unstructured":"Nilsson IM, Berntorp E, Zettervall O, Dahlback B (1990) Noncoagulation inhibitory factor VIII antibodies after induction of tolerance to factor VIII in hemophilia A patients. Blood 75: 378\u2013383","journal-title":"Blood"},{"key":"60720321277_CR28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1537-2995.1989.29589284147.x","volume":"29","author":"MV Ragni","year":"1989","unstructured":"Ragni MV, Bontempo FA, Lewis JH (1989) Disappearance of inhibitor to factor VIII in HIV-infected hemophiliacs with progression to AIDS or severe ARC. Transfusion 29: 447\u2013449","journal-title":"Transfusion"},{"key":"60720321277_CR29","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1073\/pnas.85.16.6152","volume":"85","author":"D Scandella","year":"1988","unstructured":"Scandella D, de Graaf Mahoney S, Mattingly M, Roeder D, Timmons L, Fulcher CA (1988) Epitope mapping of human factor VIII inhibitor antibodies by deletion analysis of factor VIII fragments expressed in Escherichia coli. Proc Natl Acad Sci USA 85: 6152\u20136156","journal-title":"Proc Natl Acad Sci USA"},{"key":"60720321277_CR30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0140-6736(84)90701-3","volume":"2","author":"Y Sultan","year":"1984","unstructured":"Sultan Y, Maissonneuve P, Kazatchkine MD, Nydegger VE (1984) Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet 2: 765\u2013767","journal-title":"Lancet"},{"key":"60720321277_CR31","volume-title":"Procedures for the coagulation laboratory","author":"DA Triplett","year":"1981","unstructured":"Triplett DA, Harms CS (1981) Procedures for the coagulation laboratory. ASCP Press, Chicago (manual)"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s002770050179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s002770050179\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s002770050179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T11:28:39Z","timestamp":1578396519000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s002770050179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,5]]}},"alternative-id":["60720321277"],"URL":"https:\/\/doi.org\/10.1007\/s002770050179","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,5]]}}}